Johnson & Johnson vs Pfizer Inc.: Stock Comparison
Share price, earnings, valuation and dividends side by side.
Johnson & Johnson has a market cap of $665B and Pfizer Inc. $168B, so Johnson & Johnson is about 4.0 times the size of Pfizer Inc..
Operating margin is 25.7% for Johnson & Johnson and 25.1% for Pfizer Inc..
The P/E ratio (TTM) is 41.8x for Johnson & Johnson and 38.8x for Pfizer Inc..
Dividend yield is 1.91% for Johnson & Johnson and 5.85% for Pfizer Inc..
In each row, the better figure is highlighted based only on the number itself. This does not say which is the better investment.
| JNJJohnson & JohnsonHealthcare | PFEPfizer Inc.Healthcare | |
|---|---|---|
| Basics | ||
| Market cap | $665B | $168B |
| Share price | $276.22 | $29.39 |
| 1-year return | +51.1% | +26.6% |
| 5-year return | +94.3% | −21.9% |
| Valuation | ||
| P/E (TTM) | 41.8x | 38.8x |
| Forward P/E | 24.7x | 9.9x |
| P/S | 6.7x | 2.6x |
| P/B | 7.9x | 2.0x |
| EV/EBITDA | 22.5x | 17.0x |
| Profitability | ||
| Revenue (TTM) | $99.3B | $63.7B |
| Gross margin | 68.8% | 71.3% |
| Operating margin | 25.7% | 25.1% |
| Net margin | 16.2% | 6.8% |
| ROE | 19.7% | 4.9% |
| Growth | ||
| Revenue growth (YoY) | +7.8% | — |
| Revenue CAGR (5Y) | +2.7% | +8.5% |
| EPS CAGR (5Y) | +14.9% | −3.5% |
| Dividends & balance sheet | ||
| Dividend yield | 1.91% | 5.85% |
| Years of dividend growth | — | — |
| FCF yield | 2.8% | 6.6% |
| Debt/equity (lower = less debt) | 0.58x | 0.74x |
Other comparisons
Listed mechanically from public data. Not a recommendation to buy or sell any security.